The ADAMTS14 Knockout KYSE-30 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the ADAMTS14 gene has been disrupted in the human KYSE-30 esophageal squamous cell carcinoma background. This product provides a heterogeneous pool of edited cells, each carrying targeted gene disruptions introduced by CRISPR/Cas9, enabling loss-of-function studies without the selection of a single clonal isolate. The polyclonal format preserves genetic diversity, mimicking the heterogeneity of tumor cell populations and facilitating robust analysis of ADAMTS14-dependent phenotypes in a physiologically relevant cancer model.
KYSE-30 is a well-characterized human cell line derived from a primary esophageal squamous cell carcinoma, extensively used to study the molecular mechanisms underlying esophageal cancer pathogenesis. This cell line retains key features of esophageal tumor cells, including dysregulated extracellular matrix (ECM) interactions, aberrant signaling pathways, and invasive potential. As a model system, KYSE-30 offers a tractable platform for dissecting the contributions of specific genes to cancer cell behavior, particularly those governing ECM remodeling and metastatic dissemination.
ADAMTS14 encodes a secreted procollagen N-proteinase that plays a critical role in ECM organization by cleaving procollagen types I, II, and III to generate mature collagen fibrils. Its enzymatic activity is tightly regulated by upstream factors such as TGFB1 and SMAD3, and it functions within a network that includes pro-inflammatory cytokines. ADAMTS14 interacts directly with procollagen substrates and the endogenous inhibitor TIMP3, and its activity influences downstream integrin-mediated signaling through receptors like ITGA2 and ITGB1, as well as focal adhesion components including PTK2 (FAK), TLN1, and VCL. Through these interactions, ADAMTS14 couples collagen processing to activation of TGF-beta signaling and focal adhesion dynamics, impacting cytoskeletal organization and gene expression programs.
In the context of KYSE-30 esophageal squamous cell carcinoma cells, disrupting ADAMTS14 expression is predicted to impair procollagen maturation and ECM integrity, thereby altering cell adhesion, spreading, and migratory capacity. This knockout model enables dissection of how ADAMTS14-dependent ECM remodeling influences tumor cell behavior, including the transduction of signals from the ECM via integrins to intracellular pathways that drive cancer progression. Researchers can utilize this system to probe the crosstalk between ADAMTS14 activity and TGF-beta signaling, investigating how loss of the proteinase affects cell proliferation, epithelial-mesenchymal transition, and invasive potential in a disease-relevant background.
This polyclonal knockout product is ideally suited for a range of experimental applications, including the analysis of collagen processing by Western blotting, quantification of ECM-related gene expression via RT-qPCR, and visualization of collagen fiber assembly using immunofluorescence. Functional assays such as cell migration and invasion assays, phospho-signaling analyses for TGF-beta pathway components, and co-immunoprecipitation of ADAMTS14 substrates can be employed to dissect mechanistic details. Mass spectrometry-based profiling of the ECM composition further extends the utility of this model for drug target validation and screening of therapeutic candidates. For additional details and technical support, please contact Ascent Research.
